NovaBay Pharmaceuticals (NBY) Institutional Ownership

→ Can't believe it's happening again (From Manward Press) (Ad)

Free NBY Stock Alerts

$0.08

0.00 (0.00%)

(As of 04/16/2024 ET)

Compare

Stock Analysis Chart Earnings Financials Headlines Insider Trades Ownership SEC Filings Short Interest

Current Institutional Ownership Percentage: 1.34%
Number of Institutional Buyers (last 12 months): 1
Total Institutional Inflows (last 12 months): $19.71K

Number of Institutional Sellers (last 12 months): 0

Get NBY Insider Trade Alerts

Want to know when executives and insiders are buying or selling NovaBay Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NBY Institutional Buying and Selling by Quarter

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

NovaBay Pharmaceuticals Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/11/2023	Renaissance Technologies LLC	44,923	$34K	0.0%	+139.9%	1.646%
2/15/2023	Armistice Capital LLC	148,086	$289K	0.0%	N/A	7.894%
2/13/2023	Renaissance Technologies LLC	17,423	$34K	0.0%	-96.3%	0.929%
11/14/2022	Altium Capital Management LP	1,095,957	$121K	0.0%	N/A	1.686%
8/13/2022	Renaissance Technologies LLC	409,544	$102K	0.0%	+103.5%	0.778%
5/17/2022	Virtu Financial LLC	163,451	$48K	0.0%	+260.4%	0.311%
5/13/2022	Renaissance Technologies LLC	201,222	$60K	0.0%	+57.5%	0.391%
8/17/2021	Bridgeway Capital Management LLC	155,000	$104K	0.0%	-52.3%	0.370%
8/13/2021	Vanguard Group Inc.	485,033	$326K	0.0%	+17.3%	1.156%
8/5/2021	GSA Capital Partners LLP	110,227	$74K	0.0%	N/A	0.263%
5/19/2021	Virtu Financial LLC	31,364	$29K	0.0%	-40.0%	0.075%
5/19/2021	Squarepoint Ops LLC	39,776	$36K	0.0%	N/A	0.095%
5/12/2021	Geode Capital Management LLC	147,318	$134K	0.0%	+109.1%	0.353%
3/26/2021	Susquehanna International Group LLP	60,303	$42K	0.0%	N/A	0.144%
2/10/2021	Renaissance Technologies LLC	400,393	$279K	0.0%	-34.7%	0.958%
12/11/2020	Virtu Financial LLC	46,903	$34K	0.0%	N/A	0.112%
12/1/2020	Townsquare Capital LLC	53,672	$40K	0.0%	N/A	0.128%
7/31/2020	UBS Group AG	23,460	$27K	0.0%	+649.5%	0.081%
2/13/2020	Renaissance Technologies LLC	212,557	$136K	0.0%	-38.8%	0.762%

(Data available from 1/1/2016 forward)

NBY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NBY shares?: During the previous two years, the following institutional investors and hedge funds held shares of NovaBay Pharmaceuticals shares: Armistice Capital LLC ($289K), Altium Capital Management LP ($121K), and Virtu Financial LLC ($48K), Renaissance Technologies LLC ($34K).Learn more on NBY's institutional investors.
What percentage of NovaBay Pharmaceuticals stock is owned by institutional investors?: 1.34% of NovaBay Pharmaceuticals stock is owned by institutional investors. Learn more on NBY's institutional investor holdings.
Which institutional investors have been buying NovaBay Pharmaceuticals stock?: The following institutional investors have purchased NovaBay Pharmaceuticals stock in the last 24 months: Altium Capital Management LP ($1.10M), Renaissance Technologies LLC ($308.02K), Armistice Capital LLC ($148.09K), and Virtu Financial LLC ($118.10K).

How much institutional buying is happening at NovaBay Pharmaceuticals?: Institutional investors have bought a total of 1,670,164 shares in the last 24 months. This purchase volume represents approximately $2.52M in transactions.
Which NovaBay Pharmaceuticals major shareholders have been selling company stock?: The following institutional investors have sold NovaBay Pharmaceuticals stock in the last 24 months: Renaissance Technologies LLC ($447.22K).
How much institutional selling is happening at NovaBay Pharmaceuticals?: Institutional investors have sold a total of 447,221 shares in the last 24 months. This volume of shares sold represents approximately $872.08K in transactions.

Related Companies:

This page (NYSEAMERICAN:NBY) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

NovaBay Pharmaceuticals (NBY) Institutional Ownership

NBY Institutional Buying and Selling by Quarter

NovaBay Pharmaceuticals Major Shareholders & Ownership History

NBY Institutional Ownership - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NovaBay Pharmaceuticals (NBY) Institutional Ownership

Institutional Ownership Changes (13F Filings) for NovaBay Pharmaceuticals (NYSEAMERICAN:NBY)

NBY Institutional Buying and Selling by Quarter

NovaBay Pharmaceuticals Major Shareholders & Ownership History

NBY Institutional Ownership - Frequently Asked Questions